OrsoBio, Inc.

formerly Orso Bio

Advancing first-in-class therapies to restore energy homeostasis

OrsoBio, Inc. was founded in 2022, is headquartered in Menlo Park, United States, lists 1–10 employees, and has $127.0M in recorded funding across 2 rounds.

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$127.0M
Last Round
$67.0M Series BSep 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

OrsoBio is a clinical-stage biopharmaceutical company developing first-in-class therapies to address the underlying causes of organ dysfunction in patients with severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, obesity, and nonalcoholic steatohepatitis (MASH). The company has four programs in clinical and preclinical development targeting central pathways in energy metabolism. OrsoBio's name is inspired by the remarkable metabolic adaptability of bears ("orso" in Italian) and its mission is to restore energy homeostasis in patients with severe metabolic disorders.

Summary

OrsoBio, Inc. is a Biotech company based in Menlo Park, United States, founded in 2022. It lists 1–10 employees. It has raised $127.0M in total across 2 rounds, most recently a $67.0M Series B round in Sep 2024. Investors include Ascenta Capital, Woodline Partners and Longitude Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2024
$67.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OrsoBio, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/orsobio-inc"><img src="https://indexed.vc/api/badge/company/orsobio-inc" alt="OrsoBio, Inc. on Indexed.vc" width="260" height="76" /></a>